Vir Biotechnology Inc
Ownership
Ownership Structure
Who owns Vir Biotechnology Inc (VIR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.7% of the shares are freely tradable; institutional investors hold 81.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 10.64 | 17,998,329 | +10.2 | 03/31/2026 |
| ARCH VENTURE CORP | 7.50 | 12,694,163 | -1.7 | 06/30/2026 |
| SB INVESTMENT ADVISERS (UK) LTD | 6.47 | 10,948,093 | +0.0 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 5.45 | 9,215,577 | +0.0 | 03/31/2026 |
| GSK PLC | 5.05 | 8,550,954 | +0.0 | 03/31/2026 |
| State Street Corp | 4.22 | 7,141,094 | +14.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.18 | 5,382,103 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.37 | 7,396,185 | +0.0 | 08/31/2026 |
| State Street® SPDR® S&P® Biotech ETF | 3.08 | 5,219,087 | -1.1 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.86 | 4,846,948 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| More Robert J | Director | 517,917 | 5,645,295 $ | Aug 11, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | More Robert J | Director | Other | 8,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.